Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 29,739 shares at $40.00 ($1.2M) on 2018-03-08, disclosed to the SEC on 2018-03-12.
Open-market sale of $1.2M PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 3,425 | $137K | 11.5% |
| 2 | $40.03 | 6,576 | $263K | 22.1% |
| 3 | $40.03 | 6,576 | $263K | 22.1% |
| 4 | $40.00 | 13,162 | $526K | 44.2% |
| Total | $40.01 avg | 29,739 | $1.2M | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |